Johnson Johnson Stock Cash And Equivalents

JNJ Stock

USD 155.17 0.33 0.21%

Johnson Johnson fundamentals help investors to digest information that contributes to Johnson Johnson's financial success or failures. It also enables traders to predict the movement of Johnson Stock. The fundamental analysis module provides a way to measure Johnson Johnson's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Johnson Johnson stock.

		Last Reported	Projected for Next Year
	Cash And Equivalents	4.8 B	3.1 B

The value of Cash And Equivalents is estimated to pull down to about 3.1 B.

This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Johnson Johnson Company Cash And Equivalents Analysis

Johnson Johnson's Cash or Cash Equivalents are the most liquid of all assets found on the company's balance sheet. It is used in calculating many of the firm's liquidity ratios and is a good indicator of the overall financial health of a company. Companies with a lot of cash are usually attractive takeover targets. Cash Equivalents are balance sheet items that are typically reported using currency printed on notes.

Cash

Bank Deposits

+

Liquidities

More About Cash And Equivalents | All Equity Analysis

Current Johnson Johnson Cash And Equivalents

5.37 B

Most of Johnson Johnson's fundamental indicators, such as Cash And Equivalents, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Johnson Johnson is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Johnson Cash And Equivalents Driver Correlations

Understanding the fundamental principles of building solid financial models for Johnson Johnson is extremely important. It helps to project a fair market value of Johnson Stock properly, considering its historical fundamentals such as Cash And Equivalents. Since Johnson Johnson's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Johnson Johnson's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Johnson Johnson's interrelated accounts and indicators.

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Net Receivables	Total Liab	Total Current Assets	Short Term Debt	Intangible Assets	Accounts Payable	Short Term Investments	Capital Stock	Common Stock	Long Term Debt	Good Will	Treasury Stock	Property Plant Equipment	Current Deferred Revenue	Net Tangible Assets	Long Term Debt Total	Deferred Long Term Liab	Long Term Investments	Short Long Term Debt	Cash And Equivalents	Net Invested Capital	Net Working Capital
Total Assets		0.73	0.66	0.92	0.85	0.96	0.64	0.35	0.74	0.88	0.13	0.85	0.85	0.8	0.88	-0.71	0.89	-0.01	-0.64	0.76	0.72	0.35	0.55	-0.62	0.43	-0.37
Total Stockholder Equity	0.73		0.33	0.58	0.85	0.55	0.95	0.54	0.58	0.8	0.52	0.87	0.87	0.53	0.67	-0.2	0.8	-0.07	-0.08	0.36	0.34	0.37	0.31	-0.05	0.13	-0.11
Net Debt	0.66	0.33		0.48	0.55	0.78	0.21	0.28	0.73	0.69	0.06	0.27	0.27	0.82	0.77	-0.41	0.53	-0.06	-0.78	0.81	0.77	0.45	0.77	-0.69	0.54	-0.46
Retained Earnings	0.92	0.58	0.48		0.68	0.87	0.53	0.26	0.49	0.73	0.07	0.81	0.81	0.62	0.73	-0.89	0.84	0.05	-0.54	0.66	0.59	0.32	0.5	-0.52	0.44	-0.42
Net Receivables	0.85	0.85	0.55	0.68		0.8	0.76	0.29	0.86	0.93	0.15	0.86	0.86	0.84	0.92	-0.44	0.91	0.04	-0.53	0.72	0.71	0.32	0.35	-0.48	0.08	-0.14
Total Liab	0.96	0.55	0.78	0.87	0.8		0.45	0.21	0.8	0.85	-0.05	0.71	0.71	0.89	0.92	-0.76	0.84	0.01	-0.82	0.89	0.85	0.34	0.59	-0.79	0.43	-0.41
Total Current Assets	0.64	0.95	0.21	0.53	0.76	0.45		0.5	0.45	0.73	0.67	0.83	0.83	0.45	0.54	-0.15	0.69	-0.02	0.07	0.27	0.18	0.37	0.21	0.03	0.07	0.01
Short Term Debt	0.35	0.54	0.28	0.26	0.29	0.21	0.5		0.04	0.32	0.35	0.37	0.37	0.08	0.21	-0.03	0.34	-0.3	0.11	-0.02	-0.04	0.31	0.67	0.29	0.57	-0.54
Intangible Assets	0.74	0.58	0.73	0.49	0.86	0.8	0.45	0.04		0.8	-0.03	0.6	0.6	0.93	0.9	-0.33	0.71	0.06	-0.75	0.83	0.86	0.27	0.31	-0.7	0.0	-0.07
Accounts Payable	0.88	0.8	0.69	0.73	0.93	0.85	0.73	0.32	0.8		0.26	0.77	0.77	0.85	0.94	-0.53	0.92	-0.06	-0.57	0.77	0.72	0.49	0.48	-0.57	0.32	-0.28
Short Term Investments	0.13	0.52	0.06	0.07	0.15	-0.05	0.67	0.35	-0.03	0.26		0.24	0.24	-0.02	-0.01	0.26	0.08	0.04	0.47	-0.16	-0.32	0.49	0.06	0.3	0.09	0.2
Capital Stock	0.85	0.87	0.27	0.81	0.86	0.71	0.83	0.37	0.6	0.77	0.24		1.0	0.58	0.71	-0.53	0.87	-0.01	-0.29	0.48	0.45	0.23	0.23	-0.25	0.09	-0.15
Common Stock	0.85	0.87	0.27	0.81	0.86	0.71	0.83	0.37	0.6	0.77	0.24	1.0		0.58	0.71	-0.53	0.87	-0.01	-0.29	0.48	0.45	0.23	0.23	-0.25	0.09	-0.15
Long Term Debt	0.8	0.53	0.82	0.62	0.84	0.89	0.45	0.08	0.93	0.85	-0.02	0.58	0.58		0.93	-0.52	0.76	0.04	-0.82	0.96	0.9	0.3	0.51	-0.75	0.19	-0.22
Good Will	0.88	0.67	0.77	0.73	0.92	0.92	0.54	0.21	0.9	0.94	-0.01	0.71	0.71	0.93		-0.61	0.91	0.0	-0.78	0.89	0.88	0.41	0.52	-0.69	0.27	-0.36
Treasury Stock	-0.71	-0.2	-0.41	-0.89	-0.44	-0.76	-0.15	-0.03	-0.33	-0.53	0.26	-0.53	-0.53	-0.52	-0.61		-0.69	-0.03	0.65	-0.68	-0.61	-0.22	-0.45	0.6	-0.44	0.49
Property Plant Equipment	0.89	0.8	0.53	0.84	0.91	0.84	0.69	0.34	0.71	0.92	0.08	0.87	0.87	0.76	0.91	-0.69		-0.09	-0.55	0.72	0.7	0.38	0.45	-0.46	0.29	-0.38
Current Deferred Revenue	-0.01	-0.07	-0.06	0.05	0.04	0.01	-0.02	-0.3	0.06	-0.06	0.04	-0.01	-0.01	0.04	0.0	-0.03	-0.09		-0.03	0.03	-0.05	0.06	-0.09	-0.13	-0.45	0.15
Net Tangible Assets	-0.64	-0.08	-0.78	-0.54	-0.53	-0.82	0.07	0.11	-0.75	-0.57	0.47	-0.29	-0.29	-0.82	-0.78	0.65	-0.55	-0.03		-0.89	-0.92	-0.17	-0.48	0.9	-0.28	0.38
Long Term Debt Total	0.76	0.36	0.81	0.66	0.72	0.89	0.27	-0.02	0.83	0.77	-0.16	0.48	0.48	0.96	0.89	-0.68	0.72	0.03	-0.89		0.93	0.27	0.54	-0.82	0.27	-0.3
Deferred Long Term Liab	0.72	0.34	0.77	0.59	0.71	0.85	0.18	-0.04	0.86	0.72	-0.32	0.45	0.45	0.9	0.88	-0.61	0.7	-0.05	-0.92	0.93		0.15	0.46	-0.82	0.25	-0.22
Long Term Investments	0.35	0.37	0.45	0.32	0.32	0.34	0.37	0.31	0.27	0.49	0.49	0.23	0.23	0.3	0.41	-0.22	0.38	0.06	-0.17	0.27	0.15		0.35	-0.22	0.25	-0.32
Short Long Term Debt	0.55	0.31	0.77	0.5	0.35	0.59	0.21	0.67	0.31	0.48	0.06	0.23	0.23	0.51	0.52	-0.45	0.45	-0.09	-0.48	0.54	0.46	0.35		-0.28	0.75	-0.73
Cash And Equivalents	-0.62	-0.05	-0.69	-0.52	-0.48	-0.79	0.03	0.29	-0.7	-0.57	0.3	-0.25	-0.25	-0.75	-0.69	0.6	-0.46	-0.13	0.9	-0.82	-0.82	-0.22	-0.28		-0.25	0.13
Net Invested Capital	0.43	0.13	0.54	0.44	0.08	0.43	0.07	0.57	0.0	0.32	0.09	0.09	0.09	0.19	0.27	-0.44	0.29	-0.45	-0.28	0.27	0.25	0.25	0.75	-0.25		-0.6
Net Working Capital	-0.37	-0.11	-0.46	-0.42	-0.14	-0.41	0.01	-0.54	-0.07	-0.28	0.2	-0.15	-0.15	-0.22	-0.36	0.49	-0.38	0.15	0.38	-0.3	-0.22	-0.32	-0.73	0.13	-0.6

Click cells to compare fundamentals

Johnson Cash And Equivalents Historical Pattern

Today, most investors in Johnson Johnson Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Johnson Johnson's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's cash and equivalents growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Johnson Johnson cash and equivalents as a starting point in their analysis.

Johnson Johnson Cash And Equivalents

Timeline

Cash equivalents represent current assets that are easily convertible to cash such as short term bonds, savings account, money market funds, or certificate of deposits (CDs). One of the important consideration companies make when classifying assets as cash equivalent is that investments they report on their balance sheets under current assets should have almost no risk of change in value over the next few months (usually three months).

Competition

Predict Johnson Johnson

Cash And Equivalents Over Time

In accordance with the recently published financial statements, Johnson Johnson has 5.37 B in Cash And Equivalents. This is much higher than that of the Pharmaceuticals sector and significantly higher than that of the Health Care industry. The cash and equivalents for all United States stocks is 98.66% lower than that of the firm.

Johnson Cash And Equivalents Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Johnson Johnson's direct or indirect competition against its Cash And Equivalents to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Johnson Johnson could also be used in its relative valuation, which is a method of valuing Johnson Johnson by comparing valuation metrics of similar companies.

Johnson Johnson is currently under evaluation in cash and equivalents category among its peers.

Johnson Johnson ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Johnson Johnson's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Johnson Johnson's managers, analysts, and investors.

Environmental

Governance

Social

Johnson Fundamentals

	Return On Equity	0.21
	Return On Asset	0.084
	Profit Margin	0.17 %
	Operating Margin	0.25 %
	Current Valuation	389.04 B
	Shares Outstanding	2.41 B
	Shares Owned By Insiders	0.09 %
	Shares Owned By Institutions	73.11 %
	Number Of Shares Shorted	18.11 M
	Price To Earning	24.69 X
	Price To Book	5.33 X
	Price To Sales	4.26 X
	Revenue	85.16 B
	Gross Profit	63.95 B
	EBITDA	29.34 B
	Net Income	13.33 B
	Cash And Equivalents	5.37 B
	Cash Per Share	13.03 X
	Total Debt	29.33 B
	Debt To Equity	0.43 %
	Current Ratio	1.43 X
	Book Value Per Share	29.14 X
	Cash Flow From Operations	22.79 B
	Short Ratio	3.13 X
	Earnings Per Share	6.05 X
	Price To Earnings To Growth	0.92 X
	Target Price	174.89
	Number Of Employees	131.9 K
	Beta	0.52
	Market Capitalization	373.59 B
	Total Asset	167.56 B
	Retained Earnings	153.84 B
	Working Capital	7.21 B
	Current Asset	60.21 B
	Current Liabilities	27.75 B
	Annual Yield	0.03 %
	Five Year Return	2.59 %
	Net Asset	167.56 B
	Last Dividend Paid	4.86

About Johnson Johnson Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Johnson Johnson's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Johnson Johnson using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Johnson Johnson based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Please read more on our fundamental analysis page.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

When determining whether Johnson Johnson is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Johnson Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Johnson Johnson Stock. Highlighted below are key reports to facilitate an investment decision about Johnson Johnson Stock:

How To Invest In Johnson

Details

Is Johnson Stock a good investment?

Details

What is Johnson Johnson's Net Worth?

Details

Largest Pharmaceuticals Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out Johnson Johnson Piotroski F Score and Johnson Johnson Altman Z Score analysis.

For more information on how to buy Johnson Stock please use our How to buy in Johnson Stock guide.

You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.

Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Johnson Johnson. If investors know Johnson will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Johnson Johnson listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

(0.89)

Dividend Share

4.86

Earnings Share

6.05

Revenue Per Share

36.428

Quarterly Revenue Growth

0.052

The market value of Johnson Johnson is measured differently than its book value, which is the value of Johnson that is recorded on the company's balance sheet. Investors also form their own opinion of Johnson Johnson's value that differs from its market value or its book value, called intrinsic value, which is Johnson Johnson's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Johnson Johnson's market value can be influenced by many factors that don't directly affect Johnson Johnson's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Johnson Johnson's value and its price as these two are different measures arrived at by different means. Investors typically determine if Johnson Johnson is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Johnson Johnson's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Johnson Johnson Stock Cash And Equivalents

Johnson Johnson Company Cash And Equivalents Analysis

Cash

Bank Deposits

+

Liquidities

Current Johnson Johnson Cash And Equivalents

Johnson Cash And Equivalents Driver Correlations

Johnson Cash And Equivalents Historical Pattern

Johnson Cash And Equivalents Peer Comparison

Johnson Johnson ESG Sustainability

Johnson Fundamentals

About Johnson Johnson Fundamental Analysis

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY